Skip to main content

Table 1 Membrane-associated CD147 expression and patient demographics for PCa outcomes analysis

From: CD147 expression predicts biochemical recurrence after prostatectomy independent of histologic and pathologic features

  Number (%) Mean OD (±SD) p-value
Pathologic stage    
 pT2 143 (78.1) 0.027 (±0.010) -
 pT3a 21 (11.5) 0.027 (±0.009) 0.77
 pT3b 19 (10.4) 0.021 (±0.007) 0.009
Gleason score    
 ≤6, 3 + 4 143 (78.1) 0.028 (±0.010) -
 4 + 3, ≥8 40 (21.9) 0.023 (±0.009) 0.02
Preoperative PSA (ng/ml)    
 <4 24 (13.1) 0.026 (±0.011) -
 4–10 125 (68.3) 0.027 (±0.010) 0.84
 >10 34 (18.6) 0.025 (±0.008) 0.87
Tumor volume    
 <10 % 40 (22.1) 0.026 (±0.011) -
 10–19 % 42 (23.2) 0.029 (±0.011) 0.82
 20–29 % 29 (16.0) 0.029 (±0.010) 0.27
 30–39 % 33 (18.2) 0.026 (±0.009) 0.77
 ≥40 % 37 (20.4) 0.024 (±0.010) 0.45
Recurrence status    
 Non-recur 125 (68.3) 0.028 (±0.011) -
 Recur 58 (31.7) 0.023 (±0.008) 0.001
Positive margins    
 No 88 (48.9) 0.027 (±0.010) -
 Yes 92 (51.1) 0.026 (±0.010) 0.53
Lymph node status    
 Negative 169 (95.5) 0.027 (±0.010) -
 Positive 8 (4.5) 0.022 (±0.009) 0.15
  1. Abbreviations: prostate cancer (PCa), prostate-specific antigen (PSA), optical density (OD)